Dual effects of 3, 4-methylenedioxymethamphetamine (ecstasy) on survival and apoptosis of primary hippocampal neurons

Neural Regeneration Research

Volumn 4, Issue 12, 2009, Pages 1068-1072

  Azami, Abolfazl ^a   Pasbakhsh, Parichehr ^a   Akbari, Mohammad ^a   Barbarestani, Mohammad ^a   Ghahremani, Mohammadhosein ^b   Shokrgozar, Mohammadali ^c   Mandegary, Ali ^b   Kiani, Amir ^d   Hassanzadeh, Gholamreza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c PASTEUR INSTITUTE OF IRAN   (Iran)

^d KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

3, 4 methylenedioxymethamphetamine; Apoptosis; Ecstasy; N methyl D aspartate; Neuronal culture

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; CASPASE 3; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HIPPOCAMPUS; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; RAT;

EID: 77949523066     PISSN: 16735374     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2009.12.017     Document Type: Article

References (31)

1. Simantov R. Multiple molecular and neuropharmacological effects of MDMA (Ecstasy). Life Sci. 2004;74(7):803-814.
2. Rudnick G, Wall SC. The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proc Natl Acad Sci U S A. 1992;89(5):1817-1821.
3. Ricaurte GA, McCann UD. Assessing long-term effects of MDMA (Ecstasy). Lancet. 2001;358(9296):1831-1832.
4. Reneman L, Endert E, de Bruin K, et al. The acute and chronic effects of MDMA ("ecstasy") on cortical 5-HT2A receptors in rat and human brain. Neuropsychopharmacology. 2002;26(3): 387-396.
5. Liechti ME, Saur MR, Gamma A, et al. Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT2 antagonist ketanserin in healthy humans. Neuropsychopharmacology. 2000;23(4):396-404.
6. Cole JC, Sumnall HR. The pre-clinical behavioural pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA). Neurosci Biobehav Rev. 2003;27(3):199-217.
7. Lyles J, Cadet JL. Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms. Brain Res Brain Res Rev. 2003;42(2):155-168.
8. Fantegrossi WE. In vivo pharmacology of MDMA and its enantiomers in rhesus monkeys. Exp Clin Psychopharmacol. 2008;16(1):1-12.
9. Jiménez A, Jordà EG, Verdaguer E, et al. Neurotoxicity of amphetamine derivatives is mediated by caspase pathway activation in rat cerebellar granule cells. Toxicol Appl Pharmacol. 2004;196(2):223-234.
10. Ohmori T, Abekawa T, Koyama T. The role of glutamate in behavioral and neurotoxic effects of methamphetamine. Neurochem Int. 1996;29(3):301-307.
11. Hernández M, Guerrikagoitia I, Martínez-Millan L, et al. NMDA-receptor blockade enhances cell apoptosis in the developing retina of the postnatal rat. Int J Dev Biol. 2007;51(2): 117-122.
12. Wise-Faberowski L, Pearlstein RD, Warner DS. NMDA-induced apoptosis in mixed neuronal/glial cortical cell cultures: the effects of isoflurane and dizocilpine. J Neurosurg Anesthesiol. 2006;18(4): 240-246.
13. Moriyoshi K, Masu M, Ishii T, et al. Molecular cloning and characterization of the rat NMDA receptor. Nature. 1991; 354(6348):31-37.
14. Takadera T, Sakamoto Y, Ohyashiki T. NMDA receptor 2B-selective antagonist ifenprodil-induced apoptosis was prevented by glycogen synthase kinase-3 inhibitors in cultured rat cortical neurons. Brain Res. 2004;1020(1-2):196-203.
15. Byrska B, Zuba D. Profiling of 3, 4-methylenedioxymethamphetamine by means of high-performance liquid chromatography. Anal Bioanal Chem. 2008;390(2):715-722.
16. Banker GA, Cowan WM. Rat hippocampal neurons in dispersed cell culture. Brain Res. 1977;126(3):397-342.
17. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1-2): 55-63.
18. Nicholson DW, Ali A, Thornberry NA, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 1995;376(6535):37-43.
19. Lipton JW, Tolod EG, Thompson VB, et al. 3, 4-methylenedioxy-N- methamphetamine (ecstasy) promotes the survival of fetal dopamine neurons in culture. Neuropharmacology. 2008;55(5): 851-859.
20. Sveen ML, Knudsen GM, Aznar S. No effect of MDMA (ecstasy) on cell death and 5-HT2A receptor density in organotypic rat hippocampal cultures. Neurosci Lett. 2004;362(1):6-9.
21. Bhide NS, Lipton JW, Cunningham JI, et al. Repeated exposure to MDMA provides neuroprotection against subsequent MDMAinduced serotonin depletion in brain. Brain Res. 2009;1286: 32-41.
22. Esteban B, O'Shea E, Camarero J, et al. 3, 4-methylenedioxy- methamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose. Psychopharmacology (Berl). 2001;154(3):251-260.
23. Hrometz SL, Brown AW, Nichols DE, et al. 3, 4- methylenedioxymethamphetamine (MDMA, ecstasy)-mediated production of hydrogen peroxide in an in vitro model: the role of dopamine, the serotonin-reuptake transporter, and monoamine oxidase-B. Neurosci Lett. 2004;367(1):56-59.
24. Zhao ZY, Castagnoli N Jr, Ricaurte GA, et al. Synthesis and neurotoxicological evaluation of putative metabolites of the serotonergic neurotoxin 2-(methylamino)-1-[3,4-(methylenedioxy) phenyl] propane [(methylenedioxy) methamphetamine]. Chem Res Toxicol. 1992;5(1):89-94.
25. Simantov R, Tauber M. The abused drug MDMA (Ecstasy) induces programmed death of human serotonergic cells. FASEB J. 1997;11(2):141-146.
26. Capela JP, Ruscher K, Lautenschlager M, et al. Ecstasy-induced cell death in cortical neuronal cultures is serotonin 2A-receptor-dependent and potentiated under hyperthermia. Neuroscience. 2006;139(3):1069-1081.
27. Warren MW, Zheng W, Kobeissy FH, et al. Calpain- and caspase-mediated alphaII-spectrin and tau proteolysis in rat cerebrocortical neuronal cultures after ecstasy or methamphetamine exposure. Int J Neuropsychopharmacol. 2007;10(4):479-489.
28. Liu Y, Wong TP, Aarts M, et al. NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J Neurosci. 2007;27(11):2846-2857.
29. Tang YP, Shimizu E, Dube GR, et al. Genetic enhancement of learning and memory in mice. Nature. 1999;401(6748):63-69.
30. Moyano S, Del Río J, Frechilla D. Acute and chronic effects of MDMA on molecular mechanisms implicated in memory formation in rat hippocampus: surface expression of CaMKII and NMDA receptor subunits. Pharmacol Biochem Behav. 2005;82(1): 190-199.
31. Steele TD, McCann UD, Ricaurte GA. 3, 4-methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans. Addiction. 1994;89(5): 539-551.